-transparent.png){kind=logo}
The time course of DNA binding capacity (DNA-bc) was found to correlate with the clinical course in a group of 21 patients who had biopsy-proven lupus glomerulonephritis and were treated with immunosuppressive agents. Eight patients showed a sequential DNA-bc pattern in which a high titre of anti-DNA antibody was present for a prolonged period of time all having an unfavourable clinical course. Persistently high values of DNA-bc preceded by as much as 10 months evidence of renal deterioration obtained by conventional renal function tests. Thirteen patients showed a low titre of anti-DNA antibody throughout most of their course, 12 having a favourable outcome. An initially high value of DNA-bc had no prognostic significance. These results suggest that the persistence of a high titre of anti-DNA antibody in patients with lupus glomerulonephritis is a poor prognostic sign.
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
October 1979,
Clinical nephrology,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
January 2008,
Terapevticheskii arkhiv,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
July 1977,
The American journal of medicine,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
September 2017,
Lupus,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
February 2001,
Nephron,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
March 1992,
Arthritis and rheumatism,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
June 1991,
Kidney international,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
February 1996,
Lupus,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
January 2014,
Reumatologia clinica,
M K Adler, and
A Baumgarten, and
B Hecht, and
N J Siegel
November 2020,
Lupus,
